Skip to main content

Table 1 Reported outcomes

From: Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies

Studies

Reported outcomes

Follow up period

Bias grade

Brar2008

Death, MI

9.7 months

-

I-LOVE IT 2

NACCE, death, MI, stroke, TVR, TLR, ST, all bleeding, major bleeding

12 and 18 months

B

ISAR-SAFE

Primary endpoints, death, MI, ST, stroke, TIMI major and minor bleeding, BARC bleeding

9 months

B

Tarantini2016

Death, MI, composite endpoints, stent thrombosis, BARC type 3 or 5 bleeding, stroke, revascularization

1 year

-

ARCTIC

Primary endpoints, Death, MI, ST, stroke, revascularization

17 months

B

OPTIMIZE

NACCE, death, MI, stroke, ST, major bleeding, TLR, TVR, any bleeding

1 year

B

RESET

Primary endpoints, death, MI, TVR, ST, major and minor bleeding, stroke

1 year

B

EXCELLENT

Death, MI, stroke, TVR, TLR, ST, any bleeding, TIMI major bleeding

1 year

B

PEGASUS

Death, MI, stroke, TIMI major and minor bleeding

3 years

B

DAPT

ST, MACCEs, death, stroke, MI, BARC type 2,3 or 5

12 to 30 months

B

Sardella2011

Death, MI, stroke, TIMI minor bleeding, revascularization

2 years

-

PRODIGY

Death, MI, stroke, ST, TLR, TVR, TIMI major and minor bleeding, BARC bleeding

2 years

B

Thukkani2015

Death, MI, Stroke

4 years

-

ENDEAVOR

Death, MI, ST (definite and probable), stroke, major bleeding

2 years

B

ITALIC

Primary endpoints, minor bleeding, minimal bleeding, death, MI, stroke, TVR, ST, major bleeding

1 year

B

  1. Abbreviations: MI myocardial infarction, ST stent thrombosis, TVR target vessel revascularization, TLR target lesion revascularization, NACCE net adverse clinical and cerebral events, BARC bleeding academic research consortium, TIMI thrombolysis in myocardial infarction